Information  X 
Enter a valid email address

Avacta Group PLC Ord 10P (AVCT)

Date Time Source Announcement
11 Jun 2018 7:00 am
RNS
Appointment of Non-Executive Chairman
31 May 2018 12:15 pm
EQS
Avacta (AVCT): In vivo expression of Affimers
22 May 2018 7:00 am
RNS
Successful Outcome of Study with FIT Biotech
30 Apr 2018 4:45 pm
RNS
Holding(s) in Company
17 Apr 2018 7:15 am
EQS
Avacta (AVCT): Commendable rate of progress
16 Apr 2018 7:25 am
RNS
Interim Results
09 Apr 2018 2:58 pm
RNS
Issue of Equity
29 Mar 2018 7:00 am
RNS
Avacta to Present at Investor Forum
  7:00 am
RNS
Directorate Change
13 Mar 2018 12:02 pm
RNS
Director/PDMR Shareholding
07 Mar 2018 4:35 pm
RNS
Price Monitoring Extension
08 Feb 2018 7:00 am
RNS
Summary of Capital Markets Day
22 Jan 2018 7:00 am
RNS
Avacta and OncoSec to Collaborate
18 Jan 2018 11:26 am
RNS
Result of Annual General Meeting
  7:00 am
RNS
AGM Business Update and Notice of Results
15 Jan 2018 10:58 am
RNS
HardmanResearch: Affimer Drug Conjugates a reality
  7:00 am
RNS
Drug Development Partnership with Glythera
08 Jan 2018 7:00 am
RNS
Capital Markets Day Notification
04 Jan 2018 11:04 am
RNS
PDMR Dealing and Issue of Equity
03 Jan 2018 7:00 am
RNS
Presenting at the Biotech Showcase, San Francisco
18 Dec 2017 4:28 pm
RNS
Issue of Equity
04 Dec 2017 11:03 am
RNS
Posting of Annual Report and Notice of AGM
30 Nov 2017 10:57 am
RNS
Issue of Equity
15 Nov 2017 7:00 am
RNS
Covance to Present Affimer Data at Conference
14 Nov 2017 3:27 pm
RNS
Holding(s) in Company
13 Nov 2017 7:00 am
RNS
Avacta to Present at Investor Evening
  7:00 am
RNS
Avacta to present at PEGS Europe
24 Oct 2017 7:00 am
RNS
Affimers in Scientific Publications
19 Oct 2017 7:00 am
RNS
Private Shareholder Update Event
16 Oct 2017 10:42 am
RNS
Hardman Res.: R&D accelerated to advance assets
12 Oct 2017 7:00 am
RNS
Avacta to Present at Shares Spotlight Evening
10 Oct 2017 7:00 am
RNS
Avacta to Present at Major US Conference
09 Oct 2017 4:02 pm
RNS
Director Dealing and Issue of Equity
05 Oct 2017 7:00 am
RNS
Research collaboration with FIT Biotech Oy
04 Oct 2017 7:00 am
RNS
Preliminary Results
02 Oct 2017 7:00 am
RNS
Avacta establishes US business development team
07 Sep 2017 7:00 am
RNS
Notice of Results
21 Aug 2017 12:00 pm
RNS
Director/PDMR Shareholding
07 Aug 2017 7:00 am
RNS
Trading Update
31 Jul 2017 12:00 pm
RNS
Issue of Equity
28 Jul 2017 1:15 pm
RNS
Director/PDMR Shareholding
05 Jul 2017 7:00 am
RNS
Director Dealing and Issue of Equity
04 Jul 2017 7:00 am
RNS
Manchester ShareSoc Growth Company Seminar
05 Jun 2017 7:00 am
RNS
ShareSoc Growth Company Seminar
01 Jun 2017 8:56 am
RNS
Issue of Equity
22 May 2017 7:00 am
RNS
2 Biotech's Licence Affimers for Research Use
10 May 2017 7:00 am
RNS
Key Affimer Patent To Be Granted in China
08 May 2017 1:21 pm
RNS
Hardman Research: De-risking Moderna's partnership
05 May 2017 7:00 am
RNS
Presenting at the Hardman Private Investor Forum
02 May 2017 7:00 am
RNS
Avacta to Present at BioTrinity 2017
24 Apr 2017 7:00 am
RNS
Diagnostics firm take rights to several Affimers
19 Apr 2017 7:00 am
RNS
Avacta to Present at the Shares Spotlight Evening
12 Apr 2017 7:15 am
RNS
Hardman Research: Another important box ticked
06 Apr 2017 2:23 pm
RNS
Holding(s) in Company
  2:23 pm
RNS
Holding(s) in Company
  10:22 am
RNS
Director/PDMR Shareholding
03 Apr 2017 7:00 am
RNS
Interim Results for the Period Ended 31 Jan 2017
  7:00 am
RNS
Results of Immunogenicity Study with Human Samples
31 Mar 2017 9:31 am
RNS
Avacta Presents at Investor Evening Hosted by TPI
  7:00 am
RNS
London Growth and Innovation Forum Presentation
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t